Efficacy and Safety of Pulmonary Vein Isolation in Active Duty Military Members with Atrial Fibrillation.

IF 1.1 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Military Medicine Pub Date : 2025-09-01 DOI:10.1093/milmed/usaf112

Andrew S Wilson, Andrea N Keithler, Matthew A Tunzi, Kelvin N V Bush

{"title":"Efficacy and Safety of Pulmonary Vein Isolation in Active Duty Military Members with Atrial Fibrillation.","authors":"Andrew S Wilson, Andrea N Keithler, Matthew A Tunzi, Kelvin N V Bush","doi":"10.1093/milmed/usaf112","DOIUrl":null,"url":null,"abstract":"Introduction: There is currently limited literature reviewing the role of atrial fibrillation (AF) catheter ablation in service members. This study aims to describe the efficacy and safety of AF catheter ablation in the active duty military population.Materials and methods: Military personnel with symptomatic AF who underwent ablation from 2004 to 2019 were analyzed in 4 age groups (group 1, n = 26, 18-27 years; group 2, n = 38, 28-37 years; group 3, n = 28, 38-49 years; group 4, n = 12, greater than or equal to 50 years). Primary endpoints were (1) AF control defined as no or rare AF recurrence (≤6 episodes) 3 months after last pulmonary vein isolation, and (2) procedure-related adverse events and complications.Results: A total of 104 personnel underwent 142 AF ablations with mean follow up of 55.8 ± 47 months. AF control was attained in 96.2% of group 1, 78.9% of group 2, 75.0% of group 3, and 66.7% of group 4 (P = .004). AF freedom was observed in 80.3% of group 1, 55.3% of group 2, 46.4% of group 3, 41.7% of group 4 (P = .02). Four (3.8%) complications occurred with none in the youngest group.Conclusions: AF catheter ablation is safe and most effective in younger military personnel and prospective studies are needed to confirm these findings.","PeriodicalId":18638,"journal":{"name":"Military Medicine","volume":" ","pages":"e1972-e1978"},"PeriodicalIF":1.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Military Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/milmed/usaf112","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: There is currently limited literature reviewing the role of atrial fibrillation (AF) catheter ablation in service members. This study aims to describe the efficacy and safety of AF catheter ablation in the active duty military population.

Materials and methods: Military personnel with symptomatic AF who underwent ablation from 2004 to 2019 were analyzed in 4 age groups (group 1, n = 26, 18-27 years; group 2, n = 38, 28-37 years; group 3, n = 28, 38-49 years; group 4, n = 12, greater than or equal to 50 years). Primary endpoints were (1) AF control defined as no or rare AF recurrence (≤6 episodes) 3 months after last pulmonary vein isolation, and (2) procedure-related adverse events and complications.

Results: A total of 104 personnel underwent 142 AF ablations with mean follow up of 55.8 ± 47 months. AF control was attained in 96.2% of group 1, 78.9% of group 2, 75.0% of group 3, and 66.7% of group 4 (P = .004). AF freedom was observed in 80.3% of group 1, 55.3% of group 2, 46.4% of group 3, 41.7% of group 4 (P = .02). Four (3.8%) complications occurred with none in the youngest group.

Conclusions: AF catheter ablation is safe and most effective in younger military personnel and prospective studies are needed to confirm these findings.

查看原文本刊更多论文

肺静脉隔离治疗现役军人房颤的疗效和安全性。

简介：目前关于房颤（AF）导管消融在现役军人中的作用的文献有限。本研究旨在描述房颤导管消融在现役军人中的有效性和安全性。材料与方法：选取2004 - 2019年接受消融治疗的有症状房颤军人，分为4个年龄组(第一组，n = 26, 18-27岁；第二组，n = 38, 28 ~ 37岁；第三组，n = 28, 38 ~ 49岁；第4组，n = 12，大于或等于50岁)。主要终点是(1)房颤控制，定义为在最后一次肺静脉隔离后3个月无或罕见房颤复发（≤6次），以及(2)手术相关不良事件和并发症。结果：104例患者接受房颤消融142例，平均随访55.8±47个月。1组患者房颤控制率为96.2%，2组为78.9%，3组为75.0%，4组为66.7% （P = 0.004）。1组患者房颤自由度为80.3%，2组为55.3%，3组为46.4%，4组为41.7% （P = 0.02）。4例（3.8%）并发症发生在最年轻组，无并发症发生。结论：房颤导管消融对年轻军人是安全有效的，需要前瞻性研究来证实这些发现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Military Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

2.20

自引率

8.30%

发文量

393

审稿时长

4-8 weeks

期刊介绍： Military Medicine is the official international journal of AMSUS. Articles published in the journal are peer-reviewed scientific papers, case reports, and editorials. The journal also publishes letters to the editor. The objective of the journal is to promote awareness of federal medicine by providing a forum for responsible discussion of common ideas and problems relevant to federal healthcare. Its mission is: To increase healthcare education by providing scientific and other information to its readers; to facilitate communication; and to offer a prestige publication for members’ writings.